Alpha Cognition Inc. (ACOGF)
| Previous Close | 0.8959 |
| Open | 0.8900 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.8500 - 0.8949 |
| 52 Week Range | 0.6761 - 1.8000 |
| Volume | |
| Avg. Volume | 15,027 |
| Market Cap | 52.677M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
Alpha Cognition Appoints Cedric O’Gorman, M.D., MBA as Chief Medical Officer
VANCOUVER, British Columbia, December 02, 2021--Alpha Cognition Inc. (TSX-V: ACOG)(OTCQB: ACOGF)("Alpha Cognition", or the "Company"), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, today announced the appointment of Cedric O’Gorman, M.D., as the Company’s Chief Medical Officer. Dr. O’Gorman will lead medical, clinical and regulatory functions in support of the company's clinic
- Business Wire
Alpha Cognition Reports Third Quarter of Fiscal 2021 Results
VANCOUVER, British Columbia, November 30, 2021--Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB:ACOGF) ("Alpha Cognition", or the "Company"), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, is pleased to announce that it has reported its Third Quarter financial results of fiscal 2021.
- Business Wire
Alpha Cognition to Present at LD Micro Main Event
VANCOUVER, British Columbia, October 08, 2021--Alpha Cognition Inc. (TSX-V: ACOG)(OTCQB: ACOGF)("Alpha Cognition", or the "Company"), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, is pleased to announce that it will be presenting at the 14th annual Main Event on Tuesday, October 12th at 3:00 PM EST at the Luxe Sunset Bel-Air in Los Angeles. Michael McFadden, CEO of Alpha Cogni
